Natixis’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,675
| Closed | -$76.9K | – | 1151 |
|
|
2024
Q3 | $76.9K | Sell |
1,675
-90
| -5% | -$4.13K | ﹤0.01% | 750 |
|
|
2024
Q2 | $72.1K | Sell |
1,765
-2,118
| -55% | -$86.5K | ﹤0.01% | 748 |
|
|
2024
Q1 | $99.1K | Sell |
3,883
-93
| -2% | -$2.37K | ﹤0.01% | 756 |
|
|
2023
Q4 | $36K | Sell |
3,976
-209
| -5% | -$1.89K | ﹤0.01% | 827 |
|
|
2023
Q3 | $26.7K | Sell |
4,185
-14
| -0.3% | -$89 | ﹤0.01% | 843 |
|
|
2023
Q2 | $46.6K | Sell |
4,199
-946
| -18% | -$10.5K | ﹤0.01% | 839 |
|
|
2023
Q1 | $79K | Sell |
5,145
-320
| -6% | -$4.91K | ﹤0.01% | 792 |
|
|
2022
Q4 | $121K | Buy |
+5,465
| New | +$121K | ﹤0.01% | 799 |
|